Canopy Growth (NAS:CGC) EPS without NRI

: $-1.74 (TTM As of Jun. 2023)

View and export this data going back to 2014. Start your Free Trial

Canopy Growth's earnings per share without non-recurring items for the three months ended in Jun. 2023 was $-0.05. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jun. 2023 was $-1.74.

During the past 3 years, the average earnings per share (NRI) Growth Rate was -23.00% per year. During the past 5 years, the average earnings per share (NRI) Growth Rate was -37.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Canopy Growth's EPS without NRI or its related term are showing as below:

CGC' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -298.6 Med: -29.35 Max: 34.1
Current: -23

During the past 13 years, Canopy Growth's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 34.10% per year. The lowest was -298.60% per year. And the median was -29.35% per year.

CGC's 3-Year EPS without NRI Growth Rate is ranked worse than
83.57% of 828 companies
in the Drug Manufacturers industry
Industry Median: 11.55 vs CGC: -23.00

Canopy Growth's EPS (Diluted) for the three months ended in Jun. 2023 was $-0.05. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was $-1.74.

Canopy Growth's EPS (Basic) for the three months ended in Jun. 2023 was $-0.05. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2023 was $-1.74.

Canopy Growth EPS without NRI Historical Data

The historical data trend for Canopy Growth's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Canopy Growth Annual Data

Trend

Jul13

Dec14

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

EPS without NRI

-2.06

-2.72

-3.73

-0.62

-5.17

Canopy Growth Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
EPS without NRI																-4.09	-0.35	-0.40	-0.94	-0.05

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Canopy Growth's EPS without NRI, along with its competitors' market caps and EPS without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Annual Data Quarterly Data

Canopy Growth EPS without NRI Distribution

For the Drug Manufacturers industry and Healthcare sector, Canopy Growth's EPS without NRI distribution charts can be found below:

* The bar in red indicates where Canopy Growth's EPS without NRI falls in comparison to its industry or sector. The grey bar indicates the EPS without NRI's extreme value range as defined by GuruFocus.

Canopy Growth EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock. In calculating earnings per share without non-recurring items, the dividends of preferred stocks and Non Operating Income need to subtracted from the total net income first.

EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.74

Canopy Growth (NAS:CGC) EPS without NRI Explanation

A Non Operating Income refers to an entry that appears on a company's financial statements that is unlikely to happen again. It represents a one-time expense involving an unpredictable event and is not part of a firm's normal, day-to-day operations.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Canopy Growth EPS without NRI Related Terms

Thank you for viewing the detailed overview of Canopy Growth's EPS without NRI provided by GuruFocus.com. Please click on the following links to see related term pages.

Canopy Growth (NAS:CGC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Canopy Growth Corp (NAS:CGC) » Definitions » EPS without NRI

Comparable Companies

Traded in Other Exchanges

11L1:Germany 11L1:Germany 11L1:Germany WEED:Canada

Address

1 Hershey Drive, Smiths Falls, ON, CAN, K7A 0A8

Website

https://www.canopygrowth.com

Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Doja, 7ACRES, Tweed, and Deep Space. Its non-THC products include sports drink BioSteel, skincare products under This Works, Martha Stewart CBD, and Storz & Bickel vaporizers. Canopy growth is attempting to merge its U.S. assets into a separately operated holding company, Canopy USA, which will not be consolidated into the Canadian company's financials.

Executives

Christelle Gedeon	officer: See Remarks	3 HOLLYHOCK COURT, TORONTO Z4 M3B 0B4
Garth Hankinson	director	C/O CONSTELLATION BRANDS, INC., 207 HIGH POINT DRIVE, BLDG. 100, VICTOR NY 14564
Hong Judy Eun Joo	officer: See Remarks	1 HERSHEY DRIVE, SMITHS FALLS Z4 K7A 0A8
Greenstar Ii Holdings Llc	10 percent owner	207 HIGH POINT DRIVE, BUILDING 100, VICTOR NY 14564
Greenstar Ii Llc	10 percent owner	207 HIGH POINT DRIVE, BUILDING 100, VICTOR NY 14564
Grant Julious C. Jr	officer: Chief Commercial Officer	1 HERSHEY DRIVE, SMITHS FALLS A6 K7A 0A8
Sabia James A. Jr.	director	C/O CONSTELLATION BRANDS, INC., 207 HIGH POINT DRIVE, BLDG. 100, VICTOR NY 14564
Greenstar Canada Investment Limited Partnership	10 percent owner	1055 WEST HASTINGS STREET, SUITE 1700, VANCOUVER A1 V6E 2E9
Constellation Brands Canada Holdings Ulc	10 percent owner	QUEEN'S MARQUE, 600-1741 LOWER WATER STREET, HALIFAX A5 B3J 0J2
Theresa Yanofsky	director	1 HERSHEY DRIVE, SMITHS FALLS A6 K7A 0A8
Thomas Carlton Stewart	officer: See Remarks	1 HERSHEY DRIVE, SMITHS FALLS A6 K7A 0A8
Tomas Iv Shipley	officer: See Remarks	1 HERSHEY DRIVE, SMITHS FALLS A6 K7A 0A8
Cbg Holdings Llc	10 percent owner	207 HIGH POINT DRIVE, BUILDING 100, VICTOR NY 14564
Constellation Capital Llc	10 percent owner	207 HIGH POINT DRIVE, BUILDING 100, VICTOR NY 14564
Greenstar Canada Investment Corp	10 percent owner	1055 WEST HASTINGS STREET, SUITE 1700, VANCOUVER A1 V6E 2E9